Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Myokardia Inc (MYOK)

Myokardia Inc (MYOK)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
224.91 +0.11 (+0.05%) 11/16/20 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 224.91 unch (unch) -
Quote Overview for Mon, Nov 16th, 2020
Day Low
224.52
Day High
225.00
Open 224.82
Previous Close 224.80 224.80
Volume 2,702,300 2,702,300
Avg Vol 1,087,145 1,087,145
Stochastic %K 96.51% 96.51%
Weighted Alpha +89.80 +89.80
5-Day Change +0.50 (+0.22%) +0.50 (+0.22%)
52-Week Range 42.65 - 225.00 42.65 - 225.00
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,992,876
  • Shares Outstanding, K 53,323
  • Annual Sales, $ 0 K
  • Annual Income, $ -276,210 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.84
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 14.11
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -5.64
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/09/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -1.41
  • Number of Estimates 4
  • High Estimate -1.10
  • Low Estimate -1.68
  • Prior Year -1.27
  • Growth Rate Est. (year over year) -11.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
221.90 +1.36%
on 10/20/20
Period Open: 222.00
225.00 -0.04%
on 11/16/20
+2.91 (+1.31%)
since 10/16/20
3-Month
97.83 +129.90%
on 08/20/20
Period Open: 99.24
225.00 -0.04%
on 11/16/20
+125.67 (+126.63%)
since 08/14/20
52-Week
42.65 +427.34%
on 04/02/20
Period Open: 54.95
225.00 -0.04%
on 11/16/20
+169.96 (+309.30%)
since 11/15/19

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

MyoKardia, Inc. is a biopharmaceutical company. The company focuses on discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. Its product candidate consists of MYK-461, a small molecule to reduce excessive cardiac muscle contractility...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 225.29
1st Resistance Point 225.10
Last Price 224.91
1st Support Level 224.62
2nd Support Level 224.33
3rd Support Level N/A

See More

52-Week High 225.00
Last Price 224.91
Fibonacci 61.8% 155.34
Fibonacci 50% 133.82
Fibonacci 38.2% 112.31
52-Week Low 42.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Mastering Fibonacci: The Hidden Order in Market Movements